Mishima Eikan, Inoue Chisako, Saigusa Daisuke, Inoue Ryusuke, Ito Koki, Suzuki Yusuke, Jinno Daisuke, Tsukui Yuri, Akamatsu Yosuke, Araki Masatake, Araki Kimi, Shimizu Ritsuko, Shinke Haruka, Suzuki Takehiro, Takeuchi Yoichi, Shima Hisato, Akiyama Yasutoshi, Toyohara Takafumi, Suzuki Chitose, Saiki Yoshikatu, Tominaga Teiji, Miyagi Shigehito, Kawagisihi Naoki, Soga Tomoyoshi, Ohkubo Takayoshi, Yamamura Kenichi, Imai Yutaka, Masuda Satohiro, Sabbisetti Venkata, Ichimura Takaharu, Mount David B, Bonventre Joseph V, Ito Sadayoshi, Tomioka Yoshihisa, Itoh Kunihiko, Abe Takaaki
Division of Nephrology, Endocrinology, and Vascular Medicine.
Department of Clinical Pharmacology and Genetics, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan;
J Am Soc Nephrol. 2014 Oct;25(10):2316-26. doi: 10.1681/ASN.2013091001. Epub 2014 May 15.
Tissue damage by oxidative stress is a key pathogenic mechanism in various diseases, including AKI and CKD. Thus, early detection of oxidative tissue damage is important. Using a tRNA-specific modified nucleoside 1-methyladenosine (m1A) antibody, we show that oxidative stress induces a direct conformational change in tRNA structure that promotes subsequent tRNA fragmentation and occurs much earlier than DNA damage. In various models of tissue damage (ischemic reperfusion, toxic injury, and irradiation), the levels of circulating tRNA derivatives increased rapidly. In humans, the levels of circulating tRNA derivatives also increased under conditions of acute renal ischemia, even before levels of other known tissue damage markers increased. Notably, the level of circulating free m1A correlated with mortality in the general population (n=1033) over a mean follow-up of 6.7 years. Compared with healthy controls, patients with CKD had higher levels of circulating free m1A, which were reduced by treatment with pitavastatin (2 mg/d; n=29). Therefore, tRNA damage reflects early oxidative stress damage, and detection of tRNA damage may be a useful tool for identifying organ damage and forming a clinical prognosis.
氧化应激导致的组织损伤是包括急性肾损伤(AKI)和慢性肾脏病(CKD)在内的多种疾病的关键致病机制。因此,早期检测氧化应激导致的组织损伤很重要。我们使用一种tRNA特异性修饰核苷1-甲基腺苷(m1A)抗体,发现氧化应激会诱导tRNA结构发生直接构象变化,进而促进后续的tRNA片段化,且这一过程比DNA损伤发生得更早。在各种组织损伤模型(缺血再灌注、毒性损伤和辐射)中,循环tRNA衍生物水平迅速升高。在人类中,急性肾缺血时循环tRNA衍生物水平也会升高,甚至早于其他已知组织损伤标志物水平的升高。值得注意的是,在平均随访6.7年的1033名普通人群中,循环游离m1A水平与死亡率相关。与健康对照相比,CKD患者的循环游离m1A水平更高,而匹伐他汀(2 mg/d;n = 29)治疗可降低其水平。因此,tRNA损伤反映早期氧化应激损伤,检测tRNA损伤可能是识别器官损伤和形成临床预后的有用工具